Las Vegas, NV -- (SBWIRE) -- 10/05/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: CIGNA Corporation (NYSE:CI), Community Health Systems (NYSE:CYH), PDL BioPharma Inc. (NASDAQ:PDLI), Unilife Corp (NASDAQ:UNIS)
CIGNA Corporation (NYSE:CI) managed to keep its gain at 1.45% on above-normal volume of 1.79M shares. The stock settled at $79.23 after floating in a range of $77.91 to $79.72. Its latest price has reached market capitalization of $22.41 billion. Its 52-week range has been $48.68 to $84.68. Cigna Corporation (Cigna) is a holding company. Cigna is a global health service company, with insurance subsidiaries that are providers of medical, dental, disability.
For How Long CI will fight for Profitability? Read This Trend Analysis report
Community Health Systems (NYSE:CYH) traded down on a volume of 1.77 million, lower than its standard daily volume. Shares have dropped-0.36% to $43.92. Over the last twelve months, the stock has gained 50.72% and faced a worst price of $26.33. Community Health Systems, Inc., is an operator of hospitals in the United States. The Company provides healthcare services through the hospitals that it owns and operates in non-urban and selected urban markets throughout the United States.
Has CYH Found The Bottom And Ready To Gain Momentum? Find Out Here
PDL BioPharma Inc. (NASDAQ:PDLI) settled -0.06% lower at $7.77 on above-normal volume of 1.76M shares during the last trading day. The stock has its 12-month high at $6.50 and 52-week low price was $8.48. It traded in a range of $7.71 to $7.82during the last trading day. PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.
Will PDLI Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Unilife Corp (NASDAQ:UNIS) was up on high volume, trading at a volume of 1.75M versus its average daily volume of 1.27 million shares. At $3.34, the stock has attained market capitalization of 324.59 million. Unilife Corporation (Unilife) is a developer and commercial supplier injectable drug delivery systems. The Company builds long-term collaborations with pharmaceutical and biotechnology companies seeking to utilize its differentiated devices to enable or enhance the clinical development, regulatory approval and lifecycle management of their injectable therapies.
Why Should Investors Buy UNIS After the Recent Fall? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)